Monthly Archives: September 2008

King Ups Alpharma Offer

King Pharmaceuticals sweetened its offer to purchase Alpharma this morning. The drug firm boosted the bid price to $37 per share or $1.6 billion from the initial of $33 a share it presented in early August. If Alpharma refuses, King is prepared to get down and dirty. In a pointed letter to Alpharma’s board, King […]
Posted in Deals | Tagged , , , , , , | Leave a comment

Icahn to BMS: Offer is Inadequate

In a statement to the press today, ImClone Chairman Carl Icahn said that the review committee overlooking Bristol-Myers Squibb’s offer to purchase the biotech company for $60 per share $4.5 billion just isn’t good enough. He not only accused BMS of lowballing, but also admitted that the company has been in talks with the head […]
Posted in Biotech, Deals, Strategy | Tagged , , , , , , , , | 1 Comment

Pfizer Brings Back Lipitor Ad Minus Jarvik

The Wall Street Journal posted the full video of the new Lipitor television spot. It’s very similar to the old Dr. Jarvik ads, but without the celebrity spokesperson. Pharm Exec will have more on the campaign relaunch in Wednesday’s newsletter.
Posted in Advertising, Marketing, Technology | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta